Dr. Scott Plevy reviews T cell-targeting, specifically the roles of TH1 and TH17 cells, in inflammatory bowel disease (IBD). This webcast is part of an interactive online series designed to bring you, the busy clinician, up to speed with the remarkable advances occurring every day in the field of basic and clinical immunology.

To learn more or to claim CME credit, visit http://www.ccfcme.org/TCell

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education and the R.J. Fasenmyer Center for Clinical Immunology.